The Thousand-people Assembly of
Biopharma Industry


BIOLIGN INNOVATORS WORLD



Partnering to Shape a Creative Future

April 22-23, 2023 | Guangzhou, China

Organizer & Supporter of BIOLIGN 2022

Official Partners of BIOLIGN 2022

BIOLIGN Innovators World

BIOLIGN is dedicated to building a top-level communication and display platform for Pharmas,Biotechs,CROs / CDMOs / CMOs,VCs / PEs,Digital Service Providers,Law Firms / Consultancies and Clusters / Goverment / Research Institutes / Hospitals,etc. To discover the optimal path for the future development and innovation of pharmaceuticals industry,innovation leaders will gather under one roof to share knowledge,build consensuses and analyze the cutting-edge trends and technological advances.

Spot the highlights of BIOLIGN 2022!

Download the Post-Event Report

BIOLIGN 2023 @ Guangzhou

1200+

Attendees

120+

Speakers

350+

B2B Matchmaking

70+

Sponsors

Development Strategies for the Next Decade

Part of Speakers @ BIOLIGN 2022

Xumu Zhang

RAE Foreign Member
 
 
 
 

Aimin Hui

General Manager
SharpSight Biopharma
Consulting
 
 

Kaisheng Huang

CQO
RemeGen Co., Ltd
 
 
 

Jens Ewert

Life Sciences &
Health Care Leader
Deloitte China
 
 

Jinhui Li

General Manager of
Hospital's Emergency BU
Pfizer China
 
 

Li Mao

VP, GM of Research and
Development&CMO
SciClone
 
 

Judy Deng

Head of Market Access and
Key Account Department
Novartis China
 
 

Hongwei Xie

VP
Innovent Biologics
 
 
 

Xiaoxia Zhang

VP, Global Listing Services
HKEX
 
 
 

Hong Wen

Partner
Shanghai Biomedical
Industry Equity Investment Fund
 
 

Ying Fei

Partner, M&A, Pharmaceutical
and Life Sciences,
PwC
 
 

Li Chen

Founder and
CEO,CSO
Hua Medicine
 
 

Shaojing Hu

Chairman&CEO
3H Pharmaceuticals
 
 
 

Bo Shan

CSO
Antengene
 
 
 

Dongzhou Liu

CSO & President of
Global Development
Huadong Medicine
 
 

Cheng Zhang

SVP & CSO
Gmax Biopharm LLC
 
 
 

Jianhua Su

SVP &
General Manager
EpimAb
 
 

Wenzhi Tian

Chairman and GM
ImmuneOnco
 
 
 

Ke Wu

CEO
BravoVax
 
 
 

Eric Koo

CEO
Overland ADCT BioPharma
 
 
 

Shan Gao

SVP
Suzhou Ribo
 
 
 

Yongxin Zhao

General Manager
DAC Biotech Co.,Ltd
 
 
 

Tony Guo

VP and Global Head of
Statistics and Data Sceince
BeiGene
 
 

Qiusong Tang

Head, Roche China
Accelartor
Roche
 
 

Ling Yang

VP
CTTQ
 
 
 

Hui Feng

Managing Director
&COO
Junshi Biosciences
 
 

James Yan

Chief Operating Officer, R&D
Zai Lab Limited
 
 
 

Chen Chen

VP
Simcere
 
 
 

Weimin Tang

EVP
I-Mab Biopharma
 
 
 

Liandong Ma

VP/ Head of Institute of R&D
Kintor Pharmaceutical Limited
 
 
 

Lei Fang

VP
Lepu Biopharma
 
 
 

Hena Shi

VP & GM of Oncology Division
Betta Pharmaceuticals
 
 
 

Jizu Yi

SVP
YZY BIO
 
 
 

Peng Lin

DGM
China Resources
Biomedical Co., Ltd
 
 

Lin Yang

Founder/Chairman/CEO
PersonGen BioTherapeutics
 
 
 

Wei Long

Executive VP
of Preclinical R&D
JACOBIO
 
 

Yang Lu

Founder
ShengNuo Biology
 
 
 

Yanfeng Zhang

Co-Founder/President
AlaMab Therapeutics
 
 
 

Jin Han

General Manager
Tasly Pharmaceutical
 
 
 

Ning Xi

CEO
FindCure
 
 
 

Jiong Lan

Founder&CEO
GenFleet Therapeutics
 
 
 

Hugh Davis

COO&President o
U.S. Branch
Biosion, Inc.
 
 

Yun He

VP&Technical Leader
of Antibody
Harbour BioMed
 
 

Wei Sun

CMO
Shenogen Pharma
Group
 
 

Jiguo Zhang

CBO
Stemirna Therapeutics
 
 
 

Juhong Liu

CSO
Evive Biotech
 
 
 

Jian Sheng

CEO
NeuExcell
 
 
 

Haibing Guo

Founder&CEO
WeiEn Bio
 
 
 
Guests' job information is subject to the latest information

Part of Media Partners

Industry Insights – Empowering Innovations



Selected Product & Technical White Papers



Selected Research Report from Consultancies



Exclusive Interviews of Executives and Experts

Review of BIOLIGN 2022

Formats of BIOLIGN 2023